• Clinical profile of severe asthmatics receiving biological treatment: see behind the scenes 

      Kotsiou O.S., Gourgoulianis K.I., Daniil Z. (2021)
      The clinical phenotyping of severe asthma could improve treatment outcomes, quality of life, morbidity, and mortality of asthma patients. The growing availability of rich clinical data could provide opportunities to address ...
    • Impaired Cardiovascular Response to Exercise in Patients with Severe Asthma: A Case-Control Study 

      Georgopoulou A., Fotiadou L., Tryfon S., Daniil Z., Boutou A.K. (2022)
      Background: Although asthmatics may present reduced exercise capacity, data on their cardiovascular responses during exercise testing have been scarcely investigated. The aim of this pilot case-control study is to test: ...
    • SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics 

      Papaioannou A.I., Fouka E., Tzanakis N., Antoniou K., Samitas K., Zervas E., Kostikas K., Bartziokas K., Porpodis K., Papakosta D., Tzouvelekis A., Gerogianni I., Kotsiou O., Makris M., Rovina N., Vlachou G., Markatos M., Vittorakis S., Katsoulis K., Papanikolaou I., Afthinos A., Katsaounou P., Steiropoulos P., Latsios D., Dimakou K., Koukidou S., Hillas G., Tryfon S., Kallieri M., Georgopoulou A., Avarlis P., Bakakos P., Markopoulou K., Gaki E., Paspala A., Kyriakaki Z., Gourgoulianis K.I., Papiris S., Loukides S. (2022)
      Background: At the beginning of the pandemic, there have been considerable concerns regarding coronavirus disease 2019 (COVID-19) severity and outcomes in patients with severe asthma treated with biologics. Objective: To ...
    • Serum Levels of Urokinase Plasminogen Activator Receptor (suPAR) Discriminate Moderate Uncontrolled from Severe Asthma 

      Kotsiou O.S., Pantazopoulos I., Mavrovounis G., Marsitopoulos K., Tourlakopoulos K., Kirgou P., Daniil Z., Gourgoulianis K.I. (2022)
      Introduction: The most clinically useful concept in asthma is based on the intensity of treatment required to achieve good asthma control. Biomarkers to guide therapy are needed. Aims: To investigate the role of circulating ...